A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke
Clinical trial NCT05301712 · COMPLETED
Trial details
- NCT number
- NCT05301712
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-07
- Primary completion
- 2022-10-25
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.